Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity

R Ajjan, BCB Lim, KF Standeven… - Blood, The Journal …, 2008 - ashpublications.org
Fibrinogen BβArg448Lys is a common polymorphism, positioned within the carboxyl
terminus of the Bβ-chain of the molecule. Studies suggest that it is associated with severity of …

Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications

JP Collet, Z Mishal, C Lesty, M Mirshahi… - Thrombosis and …, 1999 - thieme-connect.com
Porosity, viscoelasticity and morphological properties of plasma fibrin from 16 nephrotic
patients and 16 healthy volunteers were compared. Nephrotic patients were characterized …

What is the biological and clinical relevance of fibrin?

RI Litvinov, JW Weisel - Seminars in thrombosis and …, 2016 - thieme-connect.com
As our knowledge of the structure and functions of fibrinogen and fibrin has increased
tremendously, several key findings have given some people a superficial impression that the …

Fibrin (ogen) in cardiovascular disease: an update

W Koenig - Thrombosis and haemostasis, 2003 - thieme-connect.com
The notion that fibrinogen is strongly, consistently, and independently related to
cardiovascular risk has been widely accepted. The evidence is based on numerous …

Flow rate and fibrin fiber alignment

KC Gersh, KE Edmondson, JW Weisel - Journal of Thrombosis and …, 2010 - jthjournal.org
Fibrin clot structure strongly affects fibrinolysis rate and clot stability, and certain
characteristics have been correlated with premature myocardial infarction [1]. Consequently …

Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice

KR Machlus, JC Cardenas, FC Church… - Blood, The Journal of …, 2011 - ashpublications.org
Epidemiologic studies have correlated elevated plasma fibrinogen (hyperfibrinogenemia)
with risk of cardiovascular disease and arterial and venous thrombosis. However, it is …

[HTML][HTML] Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease

A Undas, M Celinska‐Löwenhoff, T Löwenhoff… - Journal of Thrombosis …, 2006 - Elsevier
Background: Aspirin increases fibrin clot porosity and susceptibility to lysis. It is unknown
whether other drugs, in combination with aspirin, used in the treatment of coronary artery …

Coagulation and fibrinolysis in diabetes

SH Alzahrani, RA Ajjan - Diabetes and Vascular Disease …, 2010 - journals.sagepub.com
Atherothrombotic complications are the main cause of mortality in subjects with diabetes.
Premature atherosclerosis, increased platelet reactivity and activation of coagulation factors …

Changes in clot deformability—a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarction

MC Scrutton, SB Ross-Murphy… - Blood coagulation & …, 1994 - journals.lww.com
This study examined the rheological properties of fibrin gels formed by adding thrombin to
plasma samples from 99 subjects with fibrinogen concentrations ranging from 1.45 to 4.14 …

Arterial thrombus formation in cardiovascular disease

G Lippi, M Franchini, G Targher - Nature Reviews Cardiology, 2011 - nature.com
The pathogenesis of arterial thrombosis is complex and dynamic. Unlike venous thrombi,
arterial thrombi typically form under conditions of high blood flow and are mainly composed …